Form 4 for BIIB Biogen
Accepted 2023-12-12 00:00:00 ET · period of report 2023-12-08 · accession 0001127602-23-029441 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-12 | 2023-12-08 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +351 | 4,325 | +9% | $0 |
| D | 2023-12-12 | 2023-12-08 | BIIB | Kramer Robin | CAO | F - Tax | $239.29 | -170 | 4,155 | -4% | -$40.7K |
| D | 2023-12-12 | 2023-12-08 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -351 | 351 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-08 | M | A | 351 | $0.00 | 4,324.75 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-08 | F | D | 170 | $239.29 | 4,154.75 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-12-08 | M | D | 351 | $0.00 | 351 | D | $0.00 · — to 2024-12-08 | 351 Common Stock | (F1) The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021. |